Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

UNDERSTANDING STEM-CELL EVOLUTION DYNAMICS OF DONOR CLONAL HEMATOPOIESIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION AT A SINGLE-CELL LEVEL

Award Number: F30HL162455
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS
PERIOD OF PERFORMANCE START DATE: 04/15/2022
PERIOD OF PERFORMANCE END DATE: 10/14/2024

Group Awards By:

View Award Description

UNDERSTANDING STEM-CELL EVOLUTION DYNAMICS OF DONOR CLONAL HEMATOPOIESIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION AT A SINGLE-CELL LEVEL - PROJECT SUMMARY Clonal hematopoiesis (CH), as defined by the disproportionate representation of hematopoietic clones with somatic mutations, is highly prevalent in the elderly. CH confers a risk of progression to malignancy and has been associated with increased risk of cardiovascular disease and all-cause mortality. We are interested in studying CH specifically in the context of allogeneic hematopoietic cell transplantation (HCT). Due to the increasing number of aging recipients and related donors, CH in donor samples is becoming increasingly likely. Previous studies have implicated donor CH in donor cell leukemias and an increased risk of unexplained cytopenias and chronic graft-versus-host disease, and have shown preferential expansion of CH clones post-transplant. Paradoxically, donor CH has also been associated with reduced risk of relapse. Post- transplant, donor CH clones are under particular stress due to their rapid self-renewal and the inflammatory bone marrow microenvironment. However, little is known about the clonal dynamics and evolution that occurs in the bone marrow post-transplant and how they relate to the reported outcomes. Additionally, it is not clear how CH clones represented in the hematopoietic stem cell (HSC) populations compared to differentiated cells. In this project we propose to define the clonal dynamics and evolution post-allogeneic HCT at the single cell level. Our goal is to understand the interactions between the donor and recipient clones, how they develop and distribute across hematopoietic lineages, and how donor CH clones affect these processes. To achieve this goal, we will utilize longitudinal bone marrow samples from HCT recipients collected in the first two years post- transplant. We will apply a new high-throughput single cell system that allows for simultaneous genotypic and phenotypic information for each cell. Using this information, we will be able to track the evolution, expansion, and lineage distribution of each clone, and examine the role of pre-existing donor CH clones on this process. Additionally, we will compare the clonal architectures of the bone marrow HSC population with that of total peripheral blood to identify clones that are preferentially found in HSCs and track their emergence in mature blood cells. Overall, this project will provide a greater understanding of the risks in donor CH and what drives these risks. The insights we gain will also be valuable in understanding stem cell subclonal dynamics and competition under stress conditions and leukemic progression in general.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $0 )
2026	2024	ALBERT EINSTEIN COLLEGE OF MEDICINE	1300 MORRIS PARK AVE	BRONX	NY	10461	BRONX	USA	Blood Diseases and Resources Research	000	3	1/27/2026	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2024 ( Subtotal = $26,987 )
2024	2024	ALBERT EINSTEIN COLLEGE OF MEDICINE	1300 MORRIS PARK AVE	BRONX	NY	10461	BRONX	USA	Blood Diseases and Resources Research	000	3	3/26/2024	NON-COMPETING CONTINUATION	$26,347
2024	2024	ALBERT EINSTEIN COLLEGE OF MEDICINE	1300 MORRIS PARK AVE	BRONX	NY	10461	BRONX	USA	Blood Diseases and Resources Research	001	3	8/31/2024	NON-COMPETING CONTINUATION	$640
														Subtotal = $26,987

Issue Date FY: 2023 ( Subtotal = $52,694 )
2023	2023	ALBERT EINSTEIN COLLEGE OF MEDICINE	1300 MORRIS PARK AVE	BRONX	NY	10461	BRONX	USA	Blood Diseases and Resources Research	000	2	3/21/2023	NON-COMPETING CONTINUATION	$52,694
														Subtotal = $52,694

Issue Date FY: 2022 ( Subtotal = $51,752 )
2022	2022	ALBERT EINSTEIN COLLEGE OF MEDICINE	1300 MORRIS PARK AVE	BRONX	NY	10461	BRONX	USA	Blood Diseases and Resources Research	002	1	6/30/2022	NEW	$716
2022	2022	ALBERT EINSTEIN COLLEGE OF MEDICINE	1300 MORRIS PARK AVE	BRONX	NY	10461	BRONX	USA	Blood Diseases and Resources Research	000	1	4/15/2022	NEW	$51,036
2022	2022	ALBERT EINSTEIN COLLEGE OF MEDICINE	1300 MORRIS PARK AVE	BRONX	NY	10461	BRONX	USA	Blood Diseases and Resources Research	001	1	4/15/2022	NEW	$0
														Subtotal = $51,752

Grand Total All Awards = $131,433

Top

All Categories

About

Search

Reports

Data Submission

Award Information

UNDERSTANDING STEM-CELL EVOLUTION DYNAMICS OF DONOR CLONAL HEMATOPOIESIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION AT A SINGLE-CELL LEVEL

Award Number: F30HL162455

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

PERIOD OF PERFORMANCE START DATE: 04/15/2022

PERIOD OF PERFORMANCE END DATE: 10/14/2024

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer